These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 39098116)

  • 1. Center and Individual Willingness to Consider Heart and Lung Offers From Donors With Hepatitis C.
    Ruck JM; Bowring MG; Zeiser LB; Durand CM; Massie AB; Segev DL; Kilic A; King EA; Bush EL
    J Surg Res; 2024 Oct; 302():175-185. PubMed ID: 39098116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial and Gender Disparities in Transplantation of Hepatitis C+ Hearts and Lungs.
    Hannan HA; Goldberg DS
    J Heart Lung Transplant; 2024 May; 43(5):780-786. PubMed ID: 38163451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. For your consideration: Benefits of listing as willing to consider heart offers from donors with hepatitis C.
    Ruck JM; Rodriguez E; Zhou AL; Durand CM; Massie AB; Segev DL; Polanco A; Bush EL; Kilic A
    J Thorac Cardiovasc Surg; 2024 Jun; ():. PubMed ID: 38945356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. To decline or not to decline: Consequences of decision-making regarding lung offers from donors with hepatitis C.
    Ruck JM; Bowring MG; Durand CM; Ha JS; Massie AB; Segev DL; Merlo CA; Bush EL
    J Thorac Cardiovasc Surg; 2024 Jun; 167(6):1967-1976.e2. PubMed ID: 37678605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilization and outcomes of expanded criteria donors in adults with congenital heart disease.
    Akbar AF; Zhou AL; Ruck JM; Kilic A; Cedars AM
    J Heart Lung Transplant; 2024 Oct; 43(10):1691-1700. PubMed ID: 38897425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimated impact of hepatitis C-positive lung donor utilization on US donor lung supply.
    Mooney JJ; Purington N; Mohabir P; Dhillon GS
    Am J Transplant; 2020 Jan; 20(1):289-297. PubMed ID: 31394016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes following concomitant multiorgan heart transplantation from circulatory death donors: The United States experience.
    Zhou AL; Rizaldi AA; Akbar AF; Ruck JM; King EA; Kilic A
    J Heart Lung Transplant; 2024 Aug; 43(8):1252-1262. PubMed ID: 38548240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in practice and perception of hepatitis C and liver transplantation: Results of a national survey.
    Shaffer AA; Thomas AG; Bowring MG; Van Pilsum Rasmussen SE; Cash A; Kucirka LM; Alqahtani SA; Gurakar A; Sulkowski MS; Cameron AM; Segev DL; Durand CM
    Transpl Infect Dis; 2018 Dec; 20(6):e12982. PubMed ID: 30144258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transplant Center Variability in Organ Offer Acceptance and Mortality Among US Patients on the Heart Transplant Waitlist.
    Choi AY; Mulvihill MS; Lee HJ; Zhao C; Kuchibhatla M; Schroder JN; Patel CB; Granger CB; Hartwig MG
    JAMA Cardiol; 2020 Jun; 5(6):660-668. PubMed ID: 32293647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Worldwide thoracic organ transplantation: a report from the UNOS/ISHLT International Registry for Thoracic Organ Transplantation.
    Keck BM; Bennett LE; Fiol BS; Daily OP; Novick RJ; Hosenpud JD
    Clin Transpl; 1998; ():39-52. PubMed ID: 10503084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart and Lung Transplants from HCV-Infected Donors to Uninfected Recipients.
    Woolley AE; Singh SK; Goldberg HJ; Mallidi HR; Givertz MM; Mehra MR; Coppolino A; Kusztos AE; Johnson ME; Chen K; Haddad EA; Fanikos J; Harrington DP; Camp PC; Baden LR;
    N Engl J Med; 2019 Apr; 380(17):1606-1617. PubMed ID: 30946553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Center-level trends in utilization of HCV-exposed donors for HCV-uninfected kidney and liver transplant recipients in the United States.
    Bowring MG; Shaffer AA; Massie AB; Cameron A; Desai N; Sulkowski M; Garonzik-Wang J; Segev DL
    Am J Transplant; 2019 Aug; 19(8):2329-2341. PubMed ID: 30861279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early experience with the use of hepatitis C antibody-positive, nucleic acid testing-negative donors in lung transplantation.
    Watson J; Mulvihill MS; Cox ML; Rich L; Wolfe CR; Gray A; Hartwig MG
    Clin Transplant; 2019 Mar; 33(3):e13476. PubMed ID: 30609162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thoracic organ transplants in the United States: a report from the UNOS/ISHLT Scientific Registry for Organ Transplants. United Network for Organ Sharing. International Society for Heart and Lung Transplantation.
    Keck BM; White R; Breen TJ; Daily OP; Hosenpud JD
    Clin Transpl; 1994; ():37-46. PubMed ID: 7547566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Worldwide thoracic organ transplantation: a report from the UNOS/ISHLT International Registry for thoracic organ transplantation.
    Keck BM; Bennett LE; Fiol BS; Daily OP; Novick RJ; Hosenpud JD
    Clin Transpl; 1997; ():29-43. PubMed ID: 9919389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual Procurement of Lung and Heart Allografts Does Not Negatively Affect Lung Transplant Outcomes.
    Contreras FJ; Jawitz OK; Raman V; Choi AY; Hartwig MG; Klapper JA
    J Surg Res; 2021 Mar; 259():106-113. PubMed ID: 33279835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Access to direct-acting antivirals for hepatitis C-negative transplant recipients receiving organs from hepatitis C-viremic donors.
    Bova S; Cameron A; Durand C; Katzianer J; LeGrand M; Boyer L; Glorioso J; Toman LP
    Am J Health Syst Pharm; 2022 Jan; 79(3):173-178. PubMed ID: 33987658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current status of thoracic organ transplantation and allocation in the United States.
    Coke M; Edwards LB
    Clin Transpl; 2004; ():17-26. PubMed ID: 16704135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between Declined Offers of Deceased Donor Kidney Allograft and Outcomes in Kidney Transplant Candidates.
    Husain SA; King KL; Pastan S; Patzer RE; Cohen DJ; Radhakrishnan J; Mohan S
    JAMA Netw Open; 2019 Aug; 2(8):e1910312. PubMed ID: 31469394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-course, direct-acting antivirals and ezetimibe to prevent HCV infection in recipients of organs from HCV-infected donors: a phase 3, single-centre, open-label study.
    Feld JJ; Cypel M; Kumar D; Dahari H; Pinto Ribeiro RV; Marks N; Kamkar N; Bahinskaya I; Onofrio FQ; Zahoor MA; Cerrochi O; Tinckam K; Kim SJ; Schiff J; Reichman TW; McDonald M; Alba C; Waddell TK; Sapisochin G; Selzner M; Keshavjee S; Janssen HLA; Hansen BE; Singer LG; Humar A
    Lancet Gastroenterol Hepatol; 2020 Jul; 5(7):649-657. PubMed ID: 32389183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.